http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0136923-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-826 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-465 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-182 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
| filingDate | 1984-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1989-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1989-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0136923-B1 |
| titleOfInvention | 2-amino-1,9-dihydro-6h-purin-6-one-7-oxide, the pharmaceutically acceptable salts and a process for the production thereof |
| abstract | A purified isolate of an actinomycete identified as ATCC 39364 is capable of producing the anti-microbial/antitumor compound 2-amino-1,9-dihydro-6H-purin-6-one-7-oxide.2-Amino-1,9-dihydro-6H-purin-6-one-7-oxide is produced by cultivating isolate ATCC 39364 under aerobic conditions in a culture medium containing assimilable sources of carbon and nitrogen until a substantial amount of the compound is produced and thereafter isolating the compound.The antibiotic/antitumor compound 2-amino-1,9-dihydro-6H-purin-6-one-7-oxide and pharmaceutical compositions comprising this compound or one of its pharmaceutically acceptable salts together with a pharmaceutically acceptable carrier are also disclosed. |
| priorityDate | 1983-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.